You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

May 28, 2015

Animal Feed Control: An Update on Thailand’s Legislation

Informed Counsel

Thailand’s roadmap of food safety, which was approved in 2004, aims to promote the Kingdom as the “kitchen of the world.” Animal feed, i.e., food given to farm animals, plays a major role in the food safety regime—it is part of the stages of food production, dubbed “farm-to-table,” and is an integral component in the overarching food chain. Animal feed must be as safe as meat for human consumption, and therefore registration, inspection, and control of animal feed are vigorously regulated by the regulatory authorities.

The Department of Livestock Development (DLD), Ministry of Agriculture and Cooperatives (MoAC), is the main authority responsible for putting in place a system for the management and control of animal feed. With the tremendous growth in the animal feed business, a new government unit, the Division of Animal Feed and Veterinary Products Control, was established within the DLD on September 26, 2013. This unit is responsible for the control of animal feed and hazardous substances for use in livestock production, as stipulated in the Animal Feed Quality Control Act and the Hazardous Substance Act, respectively.

Due to the rapid evolution of technology, as well as innovation in animal feed and husbandry, animal feed businesses in Thailand have expanded significantly. Much like the changes in food safety and technology, the law controlling animal feed in Thailand has evolved over time. Animal feed was previously regulated under the Animal Feed Quality Control Act B.E. 2506 (1963 Act). The 1963 Act was replaced with the Animal Feed Quality Control Act B.E. 2525 (1983 Act). Then, in 1999, there was an amendment of the Act. And very recently, the Animal Feed Quality Control Act B.E. 2558 (2015 Act) was announced in the Royal Gazette, which came into force on March 5, 2015.

Under the 2015 Act, “specific control animal feed”  must be registered prior to domestically manufacturing or importing animal feed into the Kingdom of Thailand. This term was not defined under the previous Act. The term is very broad in meaning, as it covers feed that has an impact on socioeconomic problems, feed that will probably harm animals, or feed that will have an effect on consumers of meat.

In the future, the MoAC minister will announce the type, quality standard, conditions, and requirements for registration of such animal feed. The types of animal feed that currently require registration include premix, milk products for animals, feed supplements, feed mixed with veterinary drugs, and more.

Veterinary drugs, on the other hand, are regulated by the Thai Food and Drug Administration. Animal drugs must be registered, following the Drug Act B.E. 2510 (1967), as amended. While a drug product license can be transferred from one juristic person to another, an animal feed registration license cannot be transferred. In addition, if the registered animal feed has not been manufactured or imported for two years, the MoAC minister has the power to revoke the registration license of such animal feed. These are the important precautions that animal feed companies should keep in mind.

The 2015 Act allows officers to inspect premises for the importation or manufacturing of animal feed during the daytime, in cases where unlawful action is suspected. Officers may sample the animal feed in a sufficient quantity for further analysis and testing. Under the 2015 Act, officers are also empowered to issue a requisition letter to call persons to provide testimony or submit documents for further consideration. In addition, the 2015 Act also includes additional provisions regarding the issuance of quality assurance certificates by the DLD and the termination of business.

The 2015 Act is a good sign that the responsible authorities are taking measures to preserve the wellbeing of animals and ensure food safety. Those in the animal feed business should closely monitor animal-feed-related ministerial regulations, which will likely be issued in the near future. It is expected that the 2015 Act will improve the registration and surveillance of animal feed, and ultimately, will ensure greater safety for meat consumers.

RELATED INSIGHTS​ 

July 20, 2022
What does “digital health” include within each jurisdiction? Thailand: For the most part, the idea of “digital health” or “telemedicine” has generally fallen within the area of medical device regulation in Thailand. The normal sort of digital health components you would think of—like software and device accessories for diagnosis, monitoring, prevention, or treatment of illnesses—would fall into medical device classification, so long as they do not achieve their intended function by immunological, metabolic, or pharmacological means. The “digital health” devices you commonly think of, like mobile medical apps, wearable technologies and software, fall mainly within this definition. After the last update to the Medical Device Act in 2008, Thailand next looked at digital health in 2019, with the Personal Data Protection Act (PDPA)—which is largely aligned with GDPR principles—and the Cybersecurity Act. These deal with important issues arising from “digital health” and “telemedicine” like personal data protection, consent to use and consent to transfer data, and privacy. Vietnam: Similarly, in Vietnam, while there’s not a clear definition of “digital health” in the law, it is understood to include various types of medical devices, software, and online services used for healthcare purposes—including diagnosis and treatment as well as medical records and telemedicine. There’s no law on digital health, per se, but many of these areas are covered by separate circulars issued by the Ministry of Health. There’s a circular (referred to as “Circular 49”) from late 2017 on telemedicine, for example, that actually uses the term “telemedicine” to identify the industry and sets out licensing and technical requirements. Indicators such as this show that Vietnam is definitely embracing the concept. Indonesia: In Indonesia, there is also no precise definition of “digital health.” Digital health is regulated under several laws and regulations, such as provisions concerning medical devices under the health
July 6, 2022
Patent is an essential piece of the amended Law on Intellectual Property (“Amended IP Law”), which was passed by the National Assembly of Vietnam on June 16, 2022, and will take effect on January 1, 2023 (except for the regulation on protection of experimental data for agrochemical products, which will take delayed effect on January 14, 2024). Among the amended and supplemented contents of the Amended IP Law, there are notable patent-related amendments to Article 60 on assessing the novelty of inventions and Article 96 on grounds for invalidating patent protection titles. We discuss these changes below. Secret Prior Art Under Article 60.1 A significant amendment to Clause 1, Article 60 of the Amended IP Law on the novelty of inventions is to broaden the scope under which an invention can be considered to have lost its novelty. For the first time in Vietnam, “secret prior art” –a patent application with an earlier filing date or priority date but published on or after the filing date or priority date of an examined patent application – is introduced as a prior art document. In the diagram above, at the time of filing of the A2 application, secret prior art A1 has been filed but not yet published, making it inaccessible to the public. At this point, only the A1 applicant and the IP Office are aware of the A1 application. Under the current provisions of the 2005 IP Law, as amended in 2009 and 2019, the A1 patent application is not eligible to be a prior art document when assessing the novelty of A2. However, based on the “first-to-file principle” and the principle of priority, the IP Office has still had other approaches to bar the patentability of an A2 patent application if there is such an A1 application. By
June 13, 2022
Thailand’s cannabis cultivation licensing scheme for the country’s transition toward legalization of the plant has now come to an end. The Ministry of Public Health (MOPH) announced in the Government Gazette that from June 9, 2022, “only cannabis extract with tetrahydrocannabinol (THC) of more than 0.2% by weight will be considered a narcotic.” This means that now anyone can grow, sell, or purchase cannabis seeds, plants, and inflorescence freely in Thailand, and licenses for the cultivation, possession, and distribution of cannabis are no longer required. Neither the number of cannabis plants nor the place of cultivation is restricted. It is thus the beginning of a new chapter for cannabis cultivation in Thailand, with many opining that now is a good time to enter this exciting and growing industry. The journey to this point began in 2019, when Thailand amended its laws on cannabis to allow for treatment for medical purposes, with one of the prerequisite conditions being that the cannabis must be grown in Thailand. The law was further amended to promote commercialization of the cannabis industry, allowing for cannabis to be added to food and beverages, cosmetics, and herbal products. In addition, three traditional cannabis-based formulas were listed in the universal healthcare coverage scheme, which means that almost all Thais have access to traditional cannabis recipes without cost. The successful launch of medical cannabis and its applications, and its viability as an economic industry, have become a national agenda and priority policy of the MOPH. In order to achieve the above outcomes, several legal frameworks and guidelines throughout the product’s lifecycle have been developed. For example, the Thai Food and Drug Administration (FDA) has so far granted licenses to cultivate cannabis (also known as a license to manufacture a narcotic) on more than 1,977 acres (around 800 hectares).
April 19, 2022
New technologies and production processes in the food industry have led to novel foods becoming increasingly important to both food manufacturers and the consuming public worldwide. This is very much the case across a number of jurisdictions in Southeast Asia. “Novel foods” refer to new food production processes, foods, and ingredients that have not yet been commonly used for human consumption, so these innovative foods require safety assessments before companies can produce and market them. While rules for these safety assessments are already part of novel food regulations in several other jurisdictions—such as the novel food regulations in the United Kingdom and European Union adopted in 2003, and the major reform of food safety laws in the United States passed in 2011 under the Food Modernization Act—similar rules governing the assessment of novel foods are relatively new or yet to be introduced in many parts of Asia. Nevertheless, it is important to understand the laws and practices that apply to safety assessments and the process of bringing novel foods to market in jurisdictions in the region. This article provides some clarity in this regard by summarizing important practical information on novel foods and the relevant required safety assessments in Indonesia, Thailand, and Vietnam.   Indonesia Regulator National Agency for Drug and Food Control (NADFC); frequently referred to as BPOM (Badan Pengawas Obat dan Makanan). Relevant Measures BPOM Regulation No. 27 Year 2018 concerning Public Service Standards in BPOM; Decision of the Director of Processed Food Standardization No. HK.02.02.51.511.06.21.21 Year 2021 concerning Public Service Standard Directorate Processed Food Standardization Definitions General “food ingredients” are basic fresh or processed ingredients that can be used to produce food; novel food is any food ingredient not listed in BPOM’s positive list of ingredients. Official Fees None   Process and Timeline Before submitting an